Asset Details
Do you wish to reserve the book?
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Do you wish to request the book?
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Emotions and brain function are altered up to one month after a single high dose of psilocybin
2020
Overview
Psilocybin is a classic psychedelic compound that may have efficacy for the treatment of mood and substance use disorders. Acute psilocybin effects include reduced negative mood, increased positive mood, and reduced amygdala response to negative affective stimuli. However, no study has investigated the long-term, enduring impact of psilocybin on negative affect and associated brain function. Twelve healthy volunteers (7F/5M) completed an open-label pilot study including assessments 1-day before, 1-week after, and 1-month after receiving a 25 mg/70 kg dose of psilocybin to test the hypothesis that psilocybin administration leads to enduring changes in affect and neural correlates of affect. One-week post-psilocybin, negative affect and amygdala response to facial affect stimuli were reduced, whereas positive affect and dorsal lateral prefrontal and medial orbitofrontal cortex responses to emotionally-conflicting stimuli were increased. One-month post-psilocybin, negative affective and amygdala response to facial affect stimuli returned to baseline levels while positive affect remained elevated, and trait anxiety was reduced. Finally, the number of significant resting-state functional connections across the brain increased from baseline to 1-week and 1-month post-psilocybin. These preliminary findings suggest that psilocybin may increase emotional and brain plasticity, and the reported findings support the hypothesis that negative affect may be a therapeutic target for psilocybin.
Publisher
Nature Publishing Group,Nature Publishing Group UK
Subject
/ Amygdala
/ Amygdala - diagnostic imaging
/ Anxiety
/ Cerebral Cortex - diagnostic imaging
/ Cerebral Cortex - drug effects
/ Cerebral Cortex - physiopathology
/ Drug use
/ Emotions
/ Female
/ Hallucinogens - adverse effects
/ Humans
/ Male
/ Mood
/ Nerve Net - diagnostic imaging
/ Neuronal Plasticity - drug effects
